Synovus price target raised to $60 from $56 at Truist

Truist raised the firm’s price target on Synovus (SNV) to $60 from $56 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results for Regional Banks. Loan growth commentary has skewed positive, smaller M&A deals have sprouted, and the “deregulation train has clearly left the station”, the analyst tells investors in a research note, further citing a more positive economic outlook in updating the firm’s models on the industry.